pharma · Hereditary Angioedema · Diabetic Macular Edema · KALV
Kalvista Pharmaceuticals (Ireland)
Kalvista Pharmaceuticals (Ireland) Limited
Kalvista Pharmaceuticals (Ireland) clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Framingham, USA HQ
279 Employees
Public company Type
KALV · NYSE Ticker
Company details
- Status
- Public
- HQ
- Framingham, USA
- Employees
- 279
- Programs
- 8
- Drugs
- 6
- Patents
- 24
Kalvista Pharmaceuticals (Ireland) projects
2 ClinicalTrials.gov programs sponsored by Kalvista Pharmaceuticals (Ireland).
Kalvista Pharmaceuticals (Ireland) has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Kalvista Pharmaceuticals (Ireland) have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.